VAERS reports by lot

Merck HPV lot 1696AA: VAERS reports

26 VAERS reports list lot 1696AA as a Merck HPV vaccine, received between 2012-05-31 and 2024-01-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
23%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2235%
General / Systemic (non-local)914%
Cardiac / Cardiovascular711%
Gastrointestinal610%
Dermatological (non-injection-site)58%
Allergic / Anaphylactic35%
Musculoskeletal35%
Psychiatric / Neuropsychiatric35%
Injection-site / Local reaction35%
Thrombotic / Hematological12%
Respiratory12%

Where reports came from

U.S. state of the reporter, where given (top 12).

California3
Minnesota2
Pennsylvania2
Florida2
New Jersey1
Colorado1
Alabama1
North Dakota1
Wisconsin1
Massachusetts1
Georgia1
Texas1

Reports by month received

2012-051
2012-062
2012-073
2012-087
2012-091
2012-103
2012-111
2013-021
2013-042
2013-051
2013-092
2014-061
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.